Bredis Healthcare Inc.

Bredis Healthcare Inc.

의료 및 진단 연구소

Digital solutions for mental healthcare based on ultra-sensitive biomarker analysis and machine learning technology

소개

We provide digital solutions for diagnosis, prognosis, and treatment of brain disorders. Our first target is to conquer Alzheimer's disease. The disease is a neurological disease that affects tens of millions of people around the world, and it is a very painful disease not only for the patient but also for the patient's family. As we become an aging society, the number of dementia patients and management costs are increasing significantly, and the dementia treatment market is expected to grow rapidly. Bredis Healthcare provides a variety of solutions for early diagnosis and prognosis monitoring of dementia based on ultra-sensitive detection of biomarkers in bodily fluid. We also offer various digital solutions for personalized cognitive training to prevent and treat the disease.

웹사이트
http://www.bredis.co.kr/bredishealthcare
업계
의료 및 진단 연구소
회사 규모
직원 2-10명
본사
Seoul
유형
상장기업

위치

  • 기본

    15 Teheran-ro 82-gil, Gangnam-gu

    KR Seoul

    길 보기

Bredis Healthcare Inc. 직원

업데이트

  • Bredis Healthcare Inc.님 단체 페이지 보기, 그래픽

    팔로워 58명

    Meeting Cerecin's CEO Charles and COO Lilian Chow was truly inspiring. Our discussion revealed a shared vision and aligned goals, opening exciting possibilities for collaboration. Cerecin is developing innovative drugs targeting the metabolic basis of neurological disorders like Alzheimer's disease. At Bredis Healthcare, we're working on ultra-sensitive biomarker detection technology to measure blood biomarkers related to neurological conditions. I'm profoundly grateful to Cerecin for their kind invitation. Bredis Healthcare Inc. wholeheartedly supports Cerecin's mission and vision. As we continue our work in neurological health, we look forward to potential opportunities where we can contribute to advancements in this field together. #BredisHealthcare #Cerecin #Alzheimer #DigitalELISA #DigitalImmunoassay

    Cerecin님 단체 페이지 보기, 그래픽

    팔로워 5,812명

    Cerecin CEO Charles Stacey and COO Lilian Chow were pleased to host Jina Kim while she was in Singapore at the MustConnect innovation roadshow. Bredis Healthcare Inc. is an exciting Korean 🇰🇷company with a sensitive immunoassay technology that can detect blood biomarkers specifically linked to Alzheimer’s disease. Bredis Healthcare Inc. have bold ambitions to develop a unique cohort of Asian dementia patients to support drug development and enhance patient care. We look forward to further engagement. #alzheimer’s #collaboration #KoreaBio #teamcerecin

    • 이 이미지의 대체 텍스트 설명이 없음

비슷한 페이지